Tuning lipid monolayer behavior with soluble surfactants: A pathway to enhanced ultradeformable drug carriers
European Journal of Pharmaceutics and Biopharmaceutics · 2026
DOI: 10.1016/j.ejpb.2026.115122 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026. Verfasst von Katarzyna Dopierała und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Technology and Engineering, Poznan University of Technology, Berdychowo 4, 60-965 Poznań, Poland. Electronic address: katarzyna…. Hauptthemen laut MEDLINE: Surface-Active Agents, Drug Carriers, Lipids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Ministry of Science and Higher Education of the Republic of Poland.
Abstract (Originalsprache)
Transferosomes are ultradeformable lipid vesicles used to enhance transdermal drug delivery. Their key component is the edge activator, which modulates membrane fluidity and deformability. In this study, we propose an integrated approach to evaluate the surfactants-Tween® 20, Tween® 60, Tween® 80 (Croda International), and sodium cholate (SC)-as edge activators in transferosomal formulations with 1,2-dioleoyl-3-trimethylammonium propane (DOTAP). Monolayer and bilayer investigations were combined to identify the most suitable surfactant. Among the investigated surfactants, SC exhibited the most favorable overall performance, leading to transferosomes with enhanced membrane fluidity and desirable viscoelastic properties. The results also revealed a strong influence of surfactant concentration on the interfacial behavior of the lipid bilayer, attributed to electrostatic interactions between SC and DOTAP. Atomic force microscopy confirmed increased vesicle deformability from 4.10 to 8.83 nm and reduced Young's modulus from 167.29 to 88.22 MPa for SC-containing systems compared to pure DOTAP. DLS measurements further demonstrated appropriate colloidal properties, with vesicle size of 216-345 nm. Within a simplified Quality by Design framework, SC emerged as the most promising edge activator, although adhesion-related parameters did not clearly indicate dominance of this formulation. Overall, the proposed integrated strategy provides a rational approach for the rational design of transferosomal formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Technology and Engineering, Poznan University of Technology, Berdychowo 4, 60-965 Poznań, Poland. Electronic address: katarzyna.dopierala@put.poznan.pl.
- Institute of Chemical Technology and Engineering, Poznan University of Technology, Berdychowo 4, 60-965 Poznań, Poland.
- Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
- Ernest Mario School of Pharmacy, Rutgers-The State University of New Jersey, 160 Frelinghuysen Road, Piscataway 08854, NJ, United States; Center for Dermal Research, Rutgers, The State University of New Jersey, 145 Bevi…
Förderung
- Ministry of Science and Higher Education of the Republic of Poland
Zitieren
APA
Dopierała, K., Przybylska, A., Kustrzyńska, K., & Michniak-Kohn, B. (2026). Tuning lipid monolayer behavior with soluble surfactants: A pathway to enhanced ultradeformable drug carriers. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2026.115122
Vancouver
Dopierała K, Przybylska A, Kustrzyńska K, Michniak-Kohn B. Tuning lipid monolayer behavior with soluble surfactants: A pathway to enhanced ultradeformable drug carriers. European Journal of Pharmaceutics and Biopharmaceutics. 2026. doi:10.1016/j.ejpb.2026.115122
BibTeX
@article{Dopieraa2026,
author = {Dopierała, Katarzyna and Przybylska, Alicja and Kustrzyńska, Karolina and Michniak-Kohn, Bozena},
title = {Tuning lipid monolayer behavior with soluble surfactants: A pathway to enhanced ultradeformable drug carriers},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2026},
doi = {10.1016/j.ejpb.2026.115122}
}
EUVIMED